Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy
Background: One of the leading causes of terminal renal failure is diabetic nephropathy. The aim of this study was to determine the relationship between homocysteine levels and the biomarkers of renal function, inflammation and oxidative stress, as well as the incidence of macrovascular complication...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Society of Medical Biochemists of Serbia, Belgrade
2013-01-01
|
Series: | Journal of Medical Biochemistry |
Subjects: | |
Online Access: | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2013/1452-82581302131C.pdf |
_version_ | 1818434331700363264 |
---|---|
author | Čabarkapa Velibor Đerić Mirjana Stošić Zoran Sakač Vladimir Davidović Sofija Eremić Nevena |
author_facet | Čabarkapa Velibor Đerić Mirjana Stošić Zoran Sakač Vladimir Davidović Sofija Eremić Nevena |
author_sort | Čabarkapa Velibor |
collection | DOAJ |
description | Background: One of the leading causes of terminal renal failure is diabetic nephropathy. The aim of this study was to determine the relationship between homocysteine levels and the biomarkers of renal function, inflammation and oxidative stress, as well as the incidence of macrovascular complications in patients with diabetic nephropathy. Methods: Sixty-four patients with diabetic nephropathy were included in this study. They were divided according to their homocysteine levels into two groups: hyperhomocysteinemic (HHcy, n=47) and normohomocysteinemic patients (NHCy, n=17). The results were compared to a control group (n=20) with normal renal function and without diabetes. Besides homocysteine, cystatine C, creatinine, urea, albuminuria, creatinine clearance, lipid status parameters, apolipoprotein A-I and B, lipoprotein (a), CRP, fibrinogen, oxidative LDL were determined using appropriate methods. The incidence of macro vascular diabetic complications was also determined. Results: The results indicate that the level of renal dysfunction is greater in HHcy than in NHcy patients (p<0.05). In HHcy patients levels of oxLDL were also higher compared to NHcy patients (119.3±140.4 vs. 71.4±50.8 ng/mL, disp< 0.05) as well as fibrinogen levels (4.3±1.3 vs. 3.7±0.8 g/L, p<0.05). The incidence of macrovascular complications is more frequent in HHcy than in NHcy patients (55.3. vs. 35.3 %, p>0.05), and in patients with macroalbuminuria compared to patients with microalbuminuria (65% vs. 39%, p<0.05). Conclusions: It can be concluded that HHcy is significantly present in patients with diabetic nephropathy, especially if there is greater reduction of renal function. Besides that, significantly higher concentrations of inflammatory (fibrinogen) and oxidative stress (oxLDL) markers were present in HHcy patients with diabetic nephropathy compared to NHcy patients. Therefore in diabetic nephropathy patients it is useful to regularly monitor the levels of homocysteine, as well as inflammatory and markers of oxidative stress. |
first_indexed | 2024-12-14T16:35:18Z |
format | Article |
id | doaj.art-6d6b184126e94907a962b3ee68bbc1ee |
institution | Directory Open Access Journal |
issn | 1452-8258 1452-8266 |
language | English |
last_indexed | 2024-12-14T16:35:18Z |
publishDate | 2013-01-01 |
publisher | Society of Medical Biochemists of Serbia, Belgrade |
record_format | Article |
series | Journal of Medical Biochemistry |
spelling | doaj.art-6d6b184126e94907a962b3ee68bbc1ee2022-12-21T22:54:28ZengSociety of Medical Biochemists of Serbia, BelgradeJournal of Medical Biochemistry1452-82581452-82662013-01-013221311391452-82581302131CDetermining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathyČabarkapa Velibor0https://orcid.org/0000-0001-7166-3379Đerić Mirjana1Stošić Zoran2Sakač Vladimir3Davidović Sofija4Eremić Nevena5Center for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadCenter for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadCenter for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadClinic for Nephrology and Clinical Immunology, Clinical Center of Vojvodina, Novi SadUniversity Eye Clinic, Medical Faculty, Novi SadCenter for Laboratory Medicine, Clinical Center of Vojvodina, Novi SadBackground: One of the leading causes of terminal renal failure is diabetic nephropathy. The aim of this study was to determine the relationship between homocysteine levels and the biomarkers of renal function, inflammation and oxidative stress, as well as the incidence of macrovascular complications in patients with diabetic nephropathy. Methods: Sixty-four patients with diabetic nephropathy were included in this study. They were divided according to their homocysteine levels into two groups: hyperhomocysteinemic (HHcy, n=47) and normohomocysteinemic patients (NHCy, n=17). The results were compared to a control group (n=20) with normal renal function and without diabetes. Besides homocysteine, cystatine C, creatinine, urea, albuminuria, creatinine clearance, lipid status parameters, apolipoprotein A-I and B, lipoprotein (a), CRP, fibrinogen, oxidative LDL were determined using appropriate methods. The incidence of macro vascular diabetic complications was also determined. Results: The results indicate that the level of renal dysfunction is greater in HHcy than in NHcy patients (p<0.05). In HHcy patients levels of oxLDL were also higher compared to NHcy patients (119.3±140.4 vs. 71.4±50.8 ng/mL, disp< 0.05) as well as fibrinogen levels (4.3±1.3 vs. 3.7±0.8 g/L, p<0.05). The incidence of macrovascular complications is more frequent in HHcy than in NHcy patients (55.3. vs. 35.3 %, p>0.05), and in patients with macroalbuminuria compared to patients with microalbuminuria (65% vs. 39%, p<0.05). Conclusions: It can be concluded that HHcy is significantly present in patients with diabetic nephropathy, especially if there is greater reduction of renal function. Besides that, significantly higher concentrations of inflammatory (fibrinogen) and oxidative stress (oxLDL) markers were present in HHcy patients with diabetic nephropathy compared to NHcy patients. Therefore in diabetic nephropathy patients it is useful to regularly monitor the levels of homocysteine, as well as inflammatory and markers of oxidative stress.https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2013/1452-82581302131C.pdfhomocysteinebiomarkersdiabetic nephropathy |
spellingShingle | Čabarkapa Velibor Đerić Mirjana Stošić Zoran Sakač Vladimir Davidović Sofija Eremić Nevena Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy Journal of Medical Biochemistry homocysteine biomarkers diabetic nephropathy |
title | Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy |
title_full | Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy |
title_fullStr | Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy |
title_full_unstemmed | Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy |
title_short | Determining the relationship between homocysteinemia and biomarkers of inflammation, oxidative stress and functional kidney status in patients with diabetic nephropathy |
title_sort | determining the relationship between homocysteinemia and biomarkers of inflammation oxidative stress and functional kidney status in patients with diabetic nephropathy |
topic | homocysteine biomarkers diabetic nephropathy |
url | https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2013/1452-82581302131C.pdf |
work_keys_str_mv | AT cabarkapavelibor determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy AT đericmirjana determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy AT stosiczoran determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy AT sakacvladimir determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy AT davidovicsofija determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy AT eremicnevena determiningtherelationshipbetweenhomocysteinemiaandbiomarkersofinflammationoxidativestressandfunctionalkidneystatusinpatientswithdiabeticnephropathy |